Back
Neurogene, Inc. Stock Price Chart
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
36
NGNE
Neurogene, Inc.
Last Price:
$20.30
Seasonality Move:
21.08%
7 Day Trial
ALL ACCESS PASS
$
7
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.
Neurogene, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.51 | Sell |
| 20-day SMA: | 22.8 | Sell |
| 50-day SMA: | 26 | Sell |
| 200-day SMA: | 19.71 | Buy |
| 8-day EMA: | 20.68 | Sell |
| 20-day EMA: | 22.55 | Sell |
| 50-day EMA: | 23.99 | Sell |
| 200-day EMA: | 22.86 | Sell |
Neurogene, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.96 | Sell |
| Relative Strength Index (14 RSI): | 39.14 | Sell |
| Chaikin Money Flow: | -145761 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.72 - 28.88) | Sell |
| Bollinger Bands (100): | (18.03 - 28.03) | Sell |
Neurogene, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Neurogene, Inc. Stock
Is Neurogene, Inc. Stock a Buy?
-
Neurogene, Inc. share price is 20.28 while NGNE 8-day simple moving average is 20.51, which is a Sell signal.
-
The stock price of NGNE is 20.28 while Neurogene, Inc. 20-day SMA is 22.80, which makes it a Sell.
-
Neurogene, Inc. 50-day simple moving average is 26.00 while NGNE share price is 20.28, making it a Sell technically.
-
NGNE stock price is 20.28 and Neurogene, Inc. 200-day simple moving average is 19.71, creating a Buy signal.
NGNE Technical Analysis vs Fundamental Analysis
Sell
36
Neurogene, Inc. (NGNE)
is a Sell
Is Neurogene, Inc. a Buy or a Sell?
-
Neurogene, Inc. stock is rated a SellThe current Neurogene, Inc. [NGNE] share price is $20.28. The Score for NGNE is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
Neurogene, Inc. Stock Info
Market Cap:
314.1M
Price in USD:
20.28
Share Volume:
161.3K
Neurogene, Inc. 52-Week Range
52-Week High:
37.27
52-Week Low:
6.88
Sell
36
Neurogene, Inc. (NGNE)
is a Sell
Neurogene, Inc. Share Price Forecast
-
What is the Neurogene, Inc. stock price today?The Neurogene, Inc. stock price is 20.28 USD today.
-
Will NGNE stock go up or go down?Neurogene, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Neurogene, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Neurogene, Inc. is overvalued.
Is Neurogene, Inc. Stock a Buy?
-
Neurogene, Inc. share price is 20.28 while NGNE 8-day exponential moving average is 20.68, which is a Sell signal.
-
The stock price of NGNE is 20.28 while Neurogene, Inc. 20-day EMA is 22.55, which makes it a Sell.
-
Neurogene, Inc. 50-day exponential moving average is 23.99 while NGNE share price is 20.28, making it a Sell technically.
-
NGNE stock price is 20.28 and Neurogene, Inc. 200-day simple moving average is 22.86, creating a Sell signal.
Fundamental Analysis of Neurogene, Inc.
Is Neurogene, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.26 per share, and a decrease next year of $0.71 per share.
Technical Analysis of Neurogene, Inc.
Should I short Neurogene, Inc. stock?
-
NGNE Moving Average Covergence Divergence (MACD) indicator is -1.96, suggesting Neurogene, Inc. is a Sell
-
Neurogene, Inc. Relative Strength Index (RSI) is 39.14, which suggest Neurogene, Inc. is oversold
-
The Bollinger Bands (25) for Neurogene, Inc. is (19.72 - 28.88), which suggest Neurogene, Inc. is a Sell
-
The Bollinger Bands (100) for Neurogene, Inc. is (18.03 - 28.03), which suggest Neurogene, Inc. is a Sell
* Neurogene, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.